The tumor stimulating effect of TLR7 was mediated by the downregulation of p16, cyclin D1, and PTEN, and the upregulation of p53, p27, p21, c-Myc, cyclin B1, SHPTP1, PPARγ, and TGF-β. Here, TLR7 is linked to neoplasm.